Ethyl ester Versus Triglyceride formulations of long chained omega-3 fatty acids in moderate hypertriglyceridemia - a randomized placebo-controlled clinical trial (EVT) [Et dobbelt-blindt, placebo-kontrolleret, interventionsforsog, der sammenligner den triglycerid-nedaettelnde effekt af n-3 fleruaettede fedtsyrer (n-3 PUFA), som etylester og som acylglyceroler hos patienter med moderat ikke fastende hypertriglyceridaemia].

Trial Profile

Ethyl ester Versus Triglyceride formulations of long chained omega-3 fatty acids in moderate hypertriglyceridemia - a randomized placebo-controlled clinical trial (EVT) [Et dobbelt-blindt, placebo-kontrolleret, interventionsforsog, der sammenligner den triglycerid-nedaettelnde effekt af n-3 fleruaettede fedtsyrer (n-3 PUFA), som etylester og som acylglyceroler hos patienter med moderat ikke fastende hypertriglyceridaemia].

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2014

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Acronyms EVT
  • Most Recent Events

    • 28 Jan 2014 Status changed from recruiting to completed as reported by European Clinical trial database record.
    • 18 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top